Clinical Research Solutions

Project Management and a Successful Reduction in Investigations Backlog: The Beauty and the Beast

Many of us have been faced with this beast that needs taming: a regulatory agency has conducted an inspection of your facility. Their observation is that the backlog of investigations at your site is...

Clinical Research Solutions

Understanding FDA Pre-ANDA Meetings

Brought into being by the Generic Drug User Fee Amendments Reauthorization of 2017 (GDUFA II), the FDA’s pre-ANDA program is designed to accelerate access to generic versions of complex products. The...

Clinical Research Solutions

Biomanufacturing World Summit

The Biomanufacturing World Summit brings together the “who’s who” of pharmaceutical executives and cutting-edge technology providers for North America’s premier biologics event. Make plans to attend,...

Clinical Research Solutions

How to Manage the Risk of Elemental Impurities with ICH Q3D

How to Manage the Risk of Elemental Impurities with ICH Q3D: The mission of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is to ensure...

Clinical Research Solutions

What It Takes to Be Successful with GDUFA in 2021

GDUFA II was signed into law in 2017 effectively reauthorizing GDUFA I for fiscal years 2018 through 2022. The continuing goal of the amendment is to facilitate timely access to high-quality,...

Clinical Research Solutions

The Importance of Using a Multidisciplinary Approach in Early-Stage Development for Cell and Gene Therapy Products

Implementing a multidisciplinary approach in cell and gene therapy product development is critical to the product’s eventual success or failure. In our experience, the consequence of not effectively...

Clinical Research Solutions

7 Tips to Help You Prepare for Compliance in a Post COVID-19 World

Yes, there is a light at the end of the long, dark COVID-19 tunnel, and people’s lives will return to a state of normalcy. However, what will the new state of normalcy look like in a post COVID-19...

Clinical Research Solutions

Top 9 Failure Points During Nonclinical Development

The process of drug development involves clinical and nonclinical studies. Nonclinical studies are considered crucial for understanding the safety of new drugs. Before testing a drug in people,...

Clinical Research Solutions

Stability Testing of New Drug Substances and Products

The stability of a drug substance or product is a critical attribute for all pharmaceutical products. As such, stability testing is required throughout the drug development phase as well as...

Clinical Research Solutions

The Truth Can Hurt - But Hearing It at the Right Time Can Save Time and Money

No one has an ugly baby. At least, no one thinks their baby is ugly. Every new parent thinks their baby is the most beautiful baby of all time. But the unfortunate fact is that there are ugly babies....

Prev 5 6 7 8 9